SCHEMBL23809294

SCHEMBL23809294

CC(C)c1cn(C)c2ccc(C(=O)O)nc12

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.37
KMT2A Q03164 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MMP2 P08253 1/20 0.34
MGAM O43451 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581472 0.80 KDM4E (0.46) KDM4EKMT2ATDP1CCNCCDK8
SCHEMBL23800369 0.78 KDM4E (0.39) KDM4EKMT2ATDP1CCNCCDK8
SCHEMBL23809401 0.75 ALDH1A1 (0.35) KDM4ECCNCCDK8ALOX15
SCHEMBL24453816 0.70 KDM4E (0.60) KDM4EKMT2ATDP1ALOX15TSHR
SCHEMBL21060112 0.69 SMN1; SMN2 (0.32)
SCHEMBL23809242 0.69 KMT2A (0.35) KDM4EKMT2AMEN1MTNR1AMTNR1B
SCHEMBL21060433 0.68 LMNA (0.35) MAPTL3MBTL1
SCHEMBL1554607 0.68 ACE2 (0.51) KDM4EMTNR1AMTNR1B
SCHEMBL30547717 0.67 MGAM (0.47) KDM4EKMT2ATDP1MAPTRAB9A
SCHEMBL5364529 0.67 EGLN1 (0.40) KDM4EKMT2AMAPTRAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 KDM4E 1156/4885KMT2A 824/4885TDP1 1235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.